People: argenx SE (ARGX.OQ)
Dr. Werner Lanthaler serves as Non-Executive Independent Vice Chairman of the Board at argenx SE since July 2014. Dr. Lanthaler is the chief executive officer of Evotec AG, a global drug discovery research organization, a position he has held since March 2009. Dr. Lanthaler previously served on the supervisory boards of Bioxell SpA and Pantec Biosolutions AG. Dr. Lanthaler holds a degree in psychology, a Ph. D. in business administration from Vienna University of Economics and Business and a Master’s degree in public administration from Harvard University. He is the chairman of Audit committee, and member of Remuneration and Nomination committee.
|Total Annual Compensation, EUR||55,000|
|Restricted Stock Award, EUR||--|
|Long-Term Incentive Plans, EUR||--|
|All Other, EUR||--|
|Fiscal Year Total, EUR||55,000|